Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population

被引:3
|
作者
Wang, Jun [1 ]
Wang, Jing [1 ]
Du, Yadong [1 ]
Guo, Ru [1 ]
Han, Xiqin [1 ]
Wang, Qingfeng [1 ]
Pang, Yu [2 ]
Chu, Naihui [1 ]
机构
[1] Capital Med Univ, TB Dept, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, 9 Beiguan St, Beijing, Peoples R China
[2] Capital Med Univ, Natl Clin Lab TB, Beijing Key Lab Drug Resistant TB, Beijing Chest Hosp,Beijing TB & Thorac Tumor Res, Beijing, Peoples R China
关键词
drug; first-line; plasma concentrations; tuberculosis; TUBERCULOSIS TREATMENT; ANTIMYCOBACTERIAL DRUGS; PHARMACOKINETICS; COHORT; IMPACT;
D O I
10.1097/MD.0000000000022258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We aimed to investigate the effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti- tuberculosis (TB) drugs in Chinese population. Newly diagnosed TB patients administered the anti-TB drugs under fasting conditions orally, and then had prepared breakfast at 30 minutes and 120 min after dosing, respectively. Blood sampling was also performed 120 minutes after dosing for the detection of C-max purpose. Overall, twenty-five participants were included in our analysis. The C(max)s of 30 minutes interval and 120 minutes interval were 21.8 +/- 2.0 and 19.2 +/- 2.0 mu g/mL for rifampin, 1.6 +/- 0.2 and 2.1 +/- 0.2 mu g/mL for isoniazid (INH), 1.5 +/- 0.1and 1.5 +/- 0.2 mu g/mL for ethambutol (EMB), and 49.2 +/- 3.7 and 41.5 +/- 3.9 mu g/mL for pyrazinamide, respectively. Statistical analysis revealed that there was no statistical difference between 2 groups. Additionally, 88.0% and 72.0% of the 25 participants at 2-hour interval group had peak concentrations less than the lower limit of the reference range for INH and EMB, respectively. The C(max)s of INH were 0.9 +/- 0.4 mu g/ml for rapid acetylator, which was significantly lower than those of intermediate (1.4 +/- 1.0 mu g/mL), and slow acetylator (2.5 +/- 1.0 mu g/mL), respectively (P < .01). In conclusion, our data demonstrate that early food intake at 30 minutes after drug administration had no significant influence on the plasma concentrations. In addition, a high proportion of patients receiving first-line anti-TB regimen fail to achieve the expected plasma drug ranges of INH and EMB (P > .05).
引用
收藏
页数:5
相关论文
共 24 条
  • [1] Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
    Kumar, Agibothu Kupparam Hemanth
    Chandrasekaran, Vedachalam
    Kumar, Angadi Kiran
    Kawaskar, M.
    Lavanya, J.
    Swaminathan, Soumya
    Ramachandran, Geetha
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 530 - 535
  • [2] Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations
    Cheng, Lin
    Luo, Ming
    Guo, Yan
    Fan, Yunfan
    Wang, Pengsen
    Zhou, Gang
    Qin, Shiwei
    Weng, Bangbi
    Li, Peibo
    Liu, Zhirui
    Liu, Songtao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Drug-drug interaction studies on first-line anti-tuberculosis drugs
    Bhutani, H
    Singh, S
    Jindal, KC
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (04) : 517 - 524
  • [4] Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study
    Prahl, Julie B.
    Johansen, Isik S.
    Cohen, Arieh S.
    Frimodt-Moller, Niels
    Andersen, Ase B.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2841 - 2847
  • [5] The Distribution Pattern of First-Line Anti-Tuberculosis Drug Concentrations between the Blood and the Vertebral Focus of Spinal Tuberculosis Patients
    Jiang, Guanyin
    Qin, Wanyuan
    Du, Xing
    Zhang, Ye
    Zhang, Muzi
    Xiong, Tuotuo
    Zhao, Dezhang
    Ou, Yunsheng
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [6] Comment on: Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study
    Pasipanodya, Jotam G.
    Srivastava, Shashikant
    Gumbo, Tawanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) : 320 - 321
  • [7] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Verbeeck, Roger K.
    Guenther, Gunar
    Kibuule, Dan
    Hunter, Christian
    Rennie, Tim W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (08) : 905 - 916
  • [8] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Roger K. Verbeeck
    Gunar Günther
    Dan Kibuule
    Christian Hunter
    Tim W. Rennie
    European Journal of Clinical Pharmacology, 2016, 72 : 905 - 916
  • [9] Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
    Gao, Yazhou
    Forsman, Lina Davies
    Ren, Weihua
    Zheng, Xubin
    Bao, Ziwei
    Hu, Yi
    Bruchfeld, Judith
    Alffenaar, Jan-Willem
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1347 - 1358
  • [10] There is significant relationship between Beijing genotype family strains and resistance to the first-line anti-tuberculosis drugs in the Iranian population
    Keikha, Masoud
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2020, 19